QQ客服 官方微博 反馈留言

	Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system
	An, Qing; Zheng, Yingxin; Zhao, Yirong; Liu, Tao; Guo, Huaizu; Zhang, Dapeng; Qian, Weizhu; Wang, Hao; Guo, Yajun; Hou, Sheng
刊名	DRUG DESIGN DEVELOPMENT AND THERAPY
	2019
卷号	13
关键词	infliximab biosimilar "biobetter" CMAB008 immunogenicity
ISSN号	1177-8881
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3596857
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	An, Qing,Zheng, Yingxin,Zhao, Yirong,et al. Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2019,13.
APA	An, Qing.,Zheng, Yingxin.,Zhao, Yirong.,Liu, Tao.,Guo, Huaizu.,...&Li, Jing.(2019).Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system.DRUG DESIGN DEVELOPMENT AND THERAPY,13.
MLA	An, Qing,et al."Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system".DRUG DESIGN DEVELOPMENT AND THERAPY 13(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。